Cognitive Decline in Older Persons Initiating Anticholinergic Medications

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Shah, Raj C ^a,b   Janos, Alicia L ^c   Kline, Julia E ^c   Yu, Lei ^a,b   Leurgans, Sue E ^a,b   Wilson, Robert S ^a,b   Wei, Peter ^c   Bennett, David A ^a,b   Heilman, Kenneth M ^d   Tsao, Jack W ^c,e  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e Bureau of Medicine and Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MECLOZINE; PAROXETINE; TOLTERODINE;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CLERGY; COGNITION; COGNITIVE DEFECT; COMMUNITY; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MALE; RATING SCALE; RELIGION;

AGED; AGED, 80 AND OVER; CATHOLICISM; CHOLINERGIC ANTAGONISTS; CLERGY; COGNITION; COGNITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LANGUAGE TESTS; MALE; PSYCHOLOGICAL TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84878604907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064111     Document Type: Article

References (29)

1. Barnes DE, Cauley JA, Lui LY, Fink HA, McCulloch C, et al. (2007) Women who maintain optimal cognitive function into old age. J Am Geriatr Soc 55: 259-264.
2. Yaffe K, Lindquist K, Vittinghoff E, Barnes D, Covinsky KE, et al. (2010) The effect of maintaining cognition on risk of disability and death. J Am Geriatr Soc 58: 889-894.
3. Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, et al. (2007) A Drug Burden Index to define the functional burden of medications in older people. Arch Intern Med 167: 781-787.
4. Lechevallier-Michel N, Molimard M, Dartigues JF, Fagrigoule C, Fourrier-Reglat A, (2004) Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID study. Br J Clin Pharmacol 59: 143-151.
5. Merchant RA, Li B, Yap KB, Ng TP, (2009) Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons. Age Ageing 38: 105-108.
6. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, et al. (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332: 455-459.
7. Campbell N, Boustani M, Limbil T, Ott C, Fox C, et al. (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4: 225-233.
8. Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, et al. (2009) Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-City Study. Arch Intern Med 169: 1317-1324.
9. Boustani MA, Campbell NL, Munger S, Maidment I, Fox GC, (2008) Impact of anticholinergics on the aging brain: A review and practical application. Aging Health 4: 311-320.
10. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, et al. (2011) Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 59: 1477-1483.
11. Bottigi KA, Salazar JC, Yu L, Caban-Holt AM, Ryan M, et al. (2006) Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 14: 980-984.
12. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS, (2012) Overview and findings from the Religious Orders Study. Curr Alzheimer Res 9: 628-645.
13. Wilson RS, Evans DA, Bienias JL, Mendes de Leon CF, Schneider JA, et al. (2003) Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology 61: 1479-1485.
14. Wilson RS, Mendes de Leon CF, Barnes LL, Schneider JA, et al. (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. JAMA 287: 742-748.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
16. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA, (2005) Mild cognitive impairment in different function domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 76: 1479-1484.
17. Folstein MF, Folstein SE, McHugh PR, (1975) 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
18. Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, et al. (2005) Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc 11: 400-407.
19. Hixson J, Vernier DO, (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 31: 545-548.
20. Radloff LS, (1977) The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1: 385-401.
21. McPhillips JB, Pellettera KM, Barrett-Conner E, Wingard DL, Criqui MH, (1989) Exercise patterns in a population of older adults. Am J Prev Med 5: 65-72.
22. Katz S, Akpom C, (1976) A measure of primary sociobiological functions. Int J Health Serv 6: 493-508.
23. Buchman AS, Shah RC, Leurgans SE, Boyle PA, Wilson RS, et al. (2010) Musculoskeletal pain and incident disability in community-dwelling older adults. Arthritis Care Res (Hoboken) 62: 1287-1293.
24. Fitzmaurice GM, Laird NM, Ware JH (2011) Applied Longitudinal Analysis, 2nd Edition. Wiley, New York, NY.
25. Hasselmo ME, (2006) The role of acetylcholine in learning and memory. Curr Opin Neurobiol 16: 710-715.
26. He W, Sengupta M, Velkoff VA, DeBarros KA, (2005) U.S. Census Bureau, Current Population Reports, P23-209, 65+ in the United States: U.S. Government Printing Office, Washington, DC, 2005.
27. McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T, (1984) Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34: 741-745.
28. Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, et al. (2009) Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 283: 99-106.
29. Epstein M, (1996) Aging and the kidney. J Am Soc Nephrol 7: 1106-1122.